In 2026, QA IT is becoming an increasingly strategic function within Life Science. As digitalization, cloud solutions, data analytics and AI become integral parts of core operations, we need to build quality and compliance in from the start rather than checking them afterwards.
Several clear trends are shaping this development.
First, we see a shift from traditional system validation toward continuous compliance. Agile ways of working, real-time updates and SaaS solutions require new approaches to risk assessment, documentation and validation throughout the system lifecycle.
Second, data integrity and data governance are becoming business critical. As organizations rely on larger volumes of data and AI-driven decision support, the need for traceability, transparency and clear data ownership increases. Here, QA IT plays a central role in ensuring that data is reliable, accurate and regulatory defensible.
A third key trend is that QA IT is moving closer to the business. The role is evolving from a controlling function to a strategic enabler, supporting innovation, digital transformation and more efficient processes, without compromising quality or patient safety.
Finally, there is a growing demand for specialized competence and flexibility. Many organizations currently lack sufficient QA IT expertise to meet future requirements, making consultants and interim solutions an important part of the equation.
Looking into 2026, QA IT will therefore not only be a support function, but a decisive success factor for Life Science companies aiming to combine innovation, speed and regulatory compliance.
At PharmaRelations, we support Life Science organizations in navigating the growing complexity of QA IT, from system validation and data integrity to digital transformation and continuous compliance.
Whether you are facing a specific challenge, planning a system implementation, or looking to strengthen your QA IT capabilities in 2026, our experts are here to help.
| 👉 Contact: | |
| Katarina Grip, Senior Consultant QA IT | |
| +46 70 641 16 56 | |
| katarina.grip@pharmarelations.com |
to start the conversation.